Rifaximin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rifaximin" in German language version.

refsWebsite

Global rank German rank

5nih.gov

4^th place

7^th place

2arznei-telegramm.de

low place

1,888^th place

1sigmaaldrich.com

924^th place

87^th place

1web.archive.org

1^st place

1doi.org

2^nd place

3^rd place

1aerztezeitung.de

low place

711^th place

1fda.gov

447^th place

751^st place

aerztezeitung.de

Sabine Stürmer: Innovationspreis für darmselektive Antibiose. In: Ärzte Zeitung. 22. April 2009.

arznei-telegramm.de

Arznei-Telegramm a-t 39, 2008, S. 121–3.
RIFAXIMIN (XIFAXAN) BEI REISEDURCHFALL? In: Arznei-Telegramm. Dezember 2008.

doi.org

R. Steffen, D. A. Sack, L. Riopel, Z. D. Jiang, M. Stürchler, C. D. Ericsson, B. Lowe, P. Waiyaki, M. White, H. L. DuPont: Therapy of travelers’ diarrhea with rifaximin on various continents. In: American Journal of Gastroenterology. Band 98, Nummer 5, Mai 2003, S. 1073–1078, doi:10.1111/j.1572-0241.2003.07283.x. PMID 12809830.

fda.gov

U.S. Food and Drug Administration: List of orphan products designation and approvals (PDF; 6 MB) as of October 3, 2007.

nih.gov

ncbi.nlm.nih.gov

H. L. DuPont, Z. D. Jiang, C. D. Ericsson, J. A. Adachi, J. J. Mathewson, M. W. DuPont, E. Palazzini, L. M. Riopel, D. Ashley, F. Martinez-Sandoval: Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. In: Clin Infect Dis. 33, 2001, S. 1807–1815. PMID 11692292.
P. Gionchetti, F. Rizzello, A. Venturi, F. Ugolini, M. Rossi, P. Brigidi, R. Johansson, A. Ferrieri, G. Poggioli, M. Campieri: Review-antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach. In: Eur Rev Med Pharmacol Sci. 3 (1), 1999, S. 27–30. PMID 10710827.
Z. D. Jiang, S. Ke, E. Palazzini, L. Riopel, H. Dupont: In vitro activity and fecal concentration of rifaximin after oral administration. In: Antimicrob Agents Chemother. 44 (8), 2000, S. 2205–2206. PMID 10898704; PMC 90042 (freier Volltext).
R. Steffen, D. A. Sack, L. Riopel, Z. D. Jiang, M. Stürchler, C. D. Ericsson, B. Lowe, P. Waiyaki, M. White, H. L. DuPont: Therapy of travelers’ diarrhea with rifaximin on various continents. In: American Journal of Gastroenterology. Band 98, Nummer 5, Mai 2003, S. 1073–1078, doi:10.1111/j.1572-0241.2003.07283.x. PMID 12809830.
D. N. Taylor, A. L. Bourgeois, C. D. Ericsson, R. Steffen, Z. D. Jiang, J. Halpern, R. Haake, H. L. Dupont: A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. In: The American journal of tropical medicine and hygiene. Band 74, Nummer 6, Juni 2006, S. 1060–1066. PMID 16760520.

sigmaaldrich.com

Datenblatt Rifaximin bei Sigma-Aldrich, abgerufen am 1. Dezember 2019 (PDF).

web.archive.org

Veteran Health Administration. VHA Pharmacy Benefits Management Strategic Healthcare Group and Medical Advisory Panel. National PBM Drug Monograph. Rifaximin (Xifaxan™) (Memento vom 15. Dezember 2006 im Internet Archive) (2004).